First Tracks Q2 FY26 net loss narrows to $33.37 million - TRAX News | RalliesFirst Tracks Q2 FY26 net loss narrows to $33.37 million
T
TRAX• Q2 loss narrows as R&D falls
- First Tracks posted a Q2 net loss of $33.4 million, narrowing 21.36% from a $42.4 million loss a year earlier.
- Loss per share improved to $0.95 from $1.47 in the prior-year quarter.
- R&D expense fell 34.75% to $25.6 million, due to lower rosnilimab and ANB032 costs, partly offset by higher ANB033 spending.
Cash position and upcoming ANB033 data
- Cash, cash equivalents and investments totaled $168 million.
- ANB033 celiac Cohort 1 data are due Q4 2026.
- Cohort 2 data are due Q1 2027.
- EoE data are due Q3 2027.
G&A rises on separation-related legal costs
- G&A expense rose 40.26% to $9.3 million, due to legal costs tied to the separation.
